Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Gerstmeier

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Patents|December 23, 2016
Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agentsOliver Werz, Jana Gerstmeier, Ulrike Garscha
Biochimica Et Biophysica Acta|June 7, 2014
An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesisJana Gerstmeier, Christina Weinigel, Dagmar Barz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2015
Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytesJana Gerstmeier, Christina Weinigel, Silke Rummler, et al.
PLOS Digital Health|October 17, 2025
On the road to vision zero: How unit-dose dispensing systems and health-IT are transforming clinical practicesSaskia Herrmann, Natalie Bräuer, Tobias Zimmermann, et al.
Plos One|January 16, 2026
SmUDo (Smart Unit-Dose): Redefining efficiency, quality, and staffing strategies for optimized processesJana Gerstmeier, Saskia Herrmann, Annika Demuth, et al.
Biochemical Pharmacology|February 17, 2020
Differential role of vacuolar (H<sup>+</sup>)-ATPase in the expression and activity of cyclooxygenase-2 in human monocytesZhigang Rao, Paul M Jordan, Yan Wang, et al.
Cellular and Molecular Life Sciences : CMLS|January 3, 2020
Communication between human macrophages and epithelial cancer cell lines dictates lipid mediator biosynthesisMarkus Werner, Simona Pace, Anna Czapka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2016
5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formationJana Gerstmeier, Marcia E Newcomer, Sophie Dennhardt, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 7, 2018
A 5‑lipoxygenase-specific sequence motif impedes enzyme activity and confers dependence on a partner proteinErin E Schexnaydre, Jana Gerstmeier, Ulrike Garscha, et al.
Journal of Ethnopharmacology|December 3, 2013
Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approachMayuri Napagoda, Jana Gerstmeier, Sandra Wesely, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Patents|December 23, 2016
Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agentsOliver Werz, Jana Gerstmeier, Ulrike Garscha
Biochimica Et Biophysica Acta|June 7, 2014
An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesisJana Gerstmeier, Christina Weinigel, Dagmar Barz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 24, 2015
Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytesJana Gerstmeier, Christina Weinigel, Silke Rummler, et al.
PLOS Digital Health|October 17, 2025
On the road to vision zero: How unit-dose dispensing systems and health-IT are transforming clinical practicesSaskia Herrmann, Natalie Bräuer, Tobias Zimmermann, et al.
Plos One|January 16, 2026
SmUDo (Smart Unit-Dose): Redefining efficiency, quality, and staffing strategies for optimized processesJana Gerstmeier, Saskia Herrmann, Annika Demuth, et al.
Biochemical Pharmacology|February 17, 2020
Differential role of vacuolar (H<sup>+</sup>)-ATPase in the expression and activity of cyclooxygenase-2 in human monocytesZhigang Rao, Paul M Jordan, Yan Wang, et al.
Cellular and Molecular Life Sciences : CMLS|January 3, 2020
Communication between human macrophages and epithelial cancer cell lines dictates lipid mediator biosynthesisMarkus Werner, Simona Pace, Anna Czapka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2016
5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formationJana Gerstmeier, Marcia E Newcomer, Sophie Dennhardt, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 7, 2018
A 5‑lipoxygenase-specific sequence motif impedes enzyme activity and confers dependence on a partner proteinErin E Schexnaydre, Jana Gerstmeier, Ulrike Garscha, et al.
Journal of Ethnopharmacology|December 3, 2013
Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approachMayuri Napagoda, Jana Gerstmeier, Sandra Wesely, et al.
Pageof 5